These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24846956)

  • 1. Placenta-secreted circulating markers in pregnant women with obstructive sleep apnea.
    Bourjeily G; Curran P; Butterfield K; Maredia H; Carpenter M; Lambert-Messerlian G
    J Perinat Med; 2015 Jan; 43(1):81-7. PubMed ID: 24846956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Progesterone Levels in Pregnant Women with Obstructive Sleep Apnea: A Case Control Study.
    Lee J; Eklund EE; Lambert-Messerlian G; Palomaki GE; Butterfield K; Curran P; Bourjeily G
    J Womens Health (Larchmt); 2017 Mar; 26(3):259-265. PubMed ID: 28103130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstructive sleep apnea is associated with alterations in markers of fetoplacental wellbeing.
    Bourjeily G; Butterfield K; Curran P; Lambert-Messerlian G
    J Matern Fetal Neonatal Med; 2015 Feb; 28(3):262-6. PubMed ID: 24712853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.
    Pihl K; Sørensen S; Stener Jørgensen F
    Fetal Diagn Ther; 2020; 47(4):277-283. PubMed ID: 31622970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
    Asvold BO; Eskild A; Vatten LJ
    Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
    Yu J; Shixia CZ; Wu Y; Duan T
    Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers.
    Giguère Y; Massé J; Thériault S; Bujold E; Lafond J; Rousseau F; Forest JC
    BJOG; 2015 Feb; 122(3):402-10. PubMed ID: 25175335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study.
    Karampas GA; Eleftheriades MI; Panoulis KC; Rizou MD; Haliassos AD; Metallinou DK; Mastorakos GP; Rizos DA
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():153-7. PubMed ID: 27599094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Down syndrome screening performance using first-trimester serum markers.
    Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes.
    Coolman M; Timmermans S; de Groot CJ; Russcher H; Lindemans J; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VV; Steegers EA
    Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First- and second-trimester maternal serum markers of pre-eclampsia in twin pregnancy.
    Svirsky R; Levinsohn-Tavor O; Feldman N; Klog E; Cuckle H; Maymon R
    Ultrasound Obstet Gynecol; 2016 May; 47(5):560-4. PubMed ID: 25865365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of angiogenic markers in second-trimester maternal serum from in vitro fertilization pregnancies with oocyte donation.
    Dondik Y; Pagidas K; Eklund E; Ngo C; Palomaki GE; Lambert-Messerlian G
    Fertil Steril; 2019 Dec; 112(6):1112-1117. PubMed ID: 31843087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening.
    Filippi E; Staughton J; Peregrine E; Jones P; Huttly W; Peebles DM; Pandya P; David AL
    Ultrasound Obstet Gynecol; 2011 May; 37(5):520-7. PubMed ID: 21520313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
    Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Obstructive Sleep Apnea on the Levels of Placental Growth Factor (PlGF) and Their Value for Predicting Short-Term Adverse Outcomes in Patients with Acute Coronary Syndrome.
    Barcelo A; Bauça JM; Yañez A; Fueyo L; Gomez C; de la Peña M; Pierola J; Rodriguez A; Sanchez-de-la-Torre M; Abad J; Mediano O; Amilibia J; Masdeu MJ; Teran J; Montserrat JM; Mayos M; Sanchez-de-la-Torre A; Barbé F;
    PLoS One; 2016; 11(3):e0147686. PubMed ID: 26930634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vascular endothelial growth factor family in adverse pregnancy outcomes.
    Andraweera PH; Dekker GA; Roberts CT
    Hum Reprod Update; 2012 Jul; 18(4):436-57. PubMed ID: 22495259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-β human chorionic gonadotrophin, placental growth factor, and α-fetoprotein.
    Huang T; Dennis A; Meschino WS; Rashid S; Mak-Tam E; Cuckle H
    Prenat Diagn; 2015 Jul; 35(7):709-16. PubMed ID: 25846403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester biochemical markers of placentation in screening for gestational diabetes mellitus.
    Syngelaki A; Kotecha R; Pastides A; Wright A; Nicolaides KH
    Metabolism; 2015 Nov; 64(11):1485-9. PubMed ID: 26362726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.